Atossa Therapeutics Inc（ATOS）の株価予測ATOSAtossa Therapeutics Inc

Alphio's ATOS stock price prediction model matches the current Atossa Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.16 (-0.05%). The 1-week path is $2.13 (-1.18%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Atossa Therapeutics Inc is not a good buy right now due to its current price of $2.1568, which is significantly below its 52-week high of $14.85, indicating a steep decline of 82.84% over the past year. Furthermore, the RSI is at 37.449, suggesting the stock is nearing oversold territory but has not yet shown signs of a reversal. The forward P/E ratio is 7.0423, which may seem attractive, but the company is experiencing substantial losses with a net income of -$9,589,000 in Q1 2026 and a gross profit of $0 in Q4 2024. The main risk is the company's ongoing financial struggles, as evidenced by a current ratio of 4.92, which, while still above 1, shows declining liquidity compared to previous quarters.

Atossa Therapeutics Inc (ATOS) last closed at $2.1568, gaining +6.77%. These facts feed the 1-day and 1-week ATOS price prediction above.